[HTML][HTML] Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19
CMAJ| OCTOBER 5, 2020| VOLUME 192| ISSUE 40 E1157 in thrombotic microangiopathy
by inducing tissue factor expression, secretion of von Willebrand factor, and secretion and …
by inducing tissue factor expression, secretion of von Willebrand factor, and secretion and …
Pulmonary thrombosis and thromboembolism in COVID-19
HD Poor - Chest, 2021 - Elsevier
COVID-19, the disease responsible for the devastating pandemic that began at the end of
2019, has been associated with a significantly increased risk of pulmonary thrombosis, even …
2019, has been associated with a significantly increased risk of pulmonary thrombosis, even …
[HTML][HTML] Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation
C Wang, C Yu, H Jing, X Wu, VA Novakovic… - Frontiers in Cellular …, 2022 - frontiersin.org
Many discharged COVID-19 patients affected by sequelae experience reduced quality of life
leading to an increased burden on the healthcare system, their families and society at large …
leading to an increased burden on the healthcare system, their families and society at large …
[HTML][HTML] COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
SC Cannegieter, FA Klok - Research and Practice in Thrombosis …, 2020 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative
pathogen of a new infectious disease, coronavirus disease 2019 (COVID-19), that first …
pathogen of a new infectious disease, coronavirus disease 2019 (COVID-19), that first …
Pulmonary embolism: a complication of COVID 19 infection
T Akel, F Qaqa, A Abuarqoub, F Shamoon - Thrombosis research, 2020 - Elsevier
Abstract The Coronavirus Disease 2019 (COVID 19) has been reported in almost every
country in the world. Although a large proportion of infected individuals develop only mild …
country in the world. Although a large proportion of infected individuals develop only mild …
[HTML][HTML] Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19
Abstract Coronavirus disease-2019 (COVID-19) is a rapidly evolving health crisis caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a novel …
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a novel …
[HTML][HTML] Venous thromboembolism in COVID-19
S Schulman, Y Hu… - Thrombosis and …, 2020 - thieme-connect.com
The coronavirus disease 2019 (COVID-19) is our latest pandemic, preceded by the H1N1
swine flu in 2009, which lasted approximately 19 months. One of the special characteristics …
swine flu in 2009, which lasted approximately 19 months. One of the special characteristics …
[HTML][HTML] The cross-talk between thrombosis and inflammatory storm in acute and long-COVID-19: therapeutic targets and clinical cases
D Acanfora, C Acanfora, MM Ciccone, P Scicchitano… - Viruses, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) commonly complicates
with coagulopathy. A syndrome called Long-COVID-19 is emerging recently in COVID-19 …
with coagulopathy. A syndrome called Long-COVID-19 is emerging recently in COVID-19 …
Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report.
BACKGROUND Emerging evidence shows that severe COVID-19 can be complicated by a
significant coagulopathy, that likely manifests in the form of both microthrombosis and …
significant coagulopathy, that likely manifests in the form of both microthrombosis and …
Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID‐19
PP Dobesh, TC Trujillo - Pharmacotherapy: The Journal of …, 2020 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to a worldwide
pandemic, and patients with the infection are referred to as having COVID‐19. Although …
pandemic, and patients with the infection are referred to as having COVID‐19. Although …